Antikoagulation bei der kontinuierlichen Nierenersatztherapie
暂无分享,去创建一个
[1] K. Fischer. Essentials of anticoagulation in hemodialysis , 2007, Hemodialysis international. International Symposium on Home Hemodialysis.
[2] K. Wernecke,et al. Three-year survival after four major post–cardiac operative complications* , 2006, Critical care medicine.
[3] E. de Jonge,et al. The effects of continuous venovenous hemofiltration on coagulation activation , 2006, Critical care.
[4] P. Tonner,et al. Perioperative Medikation und anästhesiologisches Management , 2006 .
[5] J. Wester,et al. Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based? , 2006, Intensive Care Medicine.
[6] G. Hafner,et al. [Monitoring of the heparin therapy during acute haemodialysis]. , 2005, Hamostaseologie.
[7] J. Floege,et al. Role of contact system activation in hemodialyzer-induced thrombogenicity. , 2001, Kidney international.
[8] C. Ronco,et al. Hirudin versus heparin for anticoagulation in continuous renal replacement therapy , 2001, Intensive Care Medicine.
[9] C. Spies,et al. Renal Dysfunction in the Perioperative Period , 2001 .
[10] A. Gullo,et al. Anaesthesia, Pain, Intensive Care and Emergency Medicine - A.P.I.C.E. , 1998, Springer Milan.
[11] R. Westendorp,et al. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. , 1996, Journal of the American Society of Nephrology : JASN.